# Correction: Nanomaterial-enabled drug delivery systems for circadian medicine: bridging direct rhythm modulation and chronotherapy

**Authors:** Muhammad Zeeshan, Juncheng Hu, Chuan-Xi Mao, Almas Danish, Ying Xiong, Muhammad Sultan Irshad, Van-Duong Dao, Zhihua Liu

PMC · DOI: 10.1039/d5ra90137e · 2025-11-19

## TL;DR

This paper corrects a previously published article on nanomaterial-based drug delivery systems for circadian medicine.

## Contribution

The paper provides corrections to the original study's content or references.

## Key findings

- The corrections address errors in the original publication.
- The revised information ensures accuracy in the field of circadian medicine and drug delivery systems.

## Abstract

Correction for “Nanomaterial-enabled drug delivery systems for circadian medicine: bridging direct rhythm modulation and chronotherapy” by Muhammad Zeeshan et al., RSC Adv., 2025, 15, 31981–32008, https://doi.org/10.1039/D5RA04137F.

## Full-text entities

- **Genes:** RORA (RAR related orphan receptor A) [NCBI Gene 6095] {aka IDDECA, NR1F1, ROR1, ROR2, ROR3, RORa1}, BMAL1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 406] {aka ARNTL, ARNTL1, BMAL1c, JAP3, MOP3, PASD3}, CLOCK (clock circadian regulator) [NCBI Gene 9575] {aka KAT13D, bHLHe8}

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12628127/full.md

---
Source: https://tomesphere.com/paper/PMC12628127